Abstract
In recent years, most cDNA microarray studies of chemotherapeutic drug resistance have not considered the temporal pattern of gene expression. The objective of this study was to examine systematically changes in gene expression of NCI-H226 and NCI-H2170 lung cancer cells treated weekly with IC10 doses of cisplatin. NCI-H226 lung cancer cells were treated weekly with an IC10 dose of cisplatin. Candidate genes with a fold change of 2.0 or more were identified from this study. A second experiment was conducted by exposing NCI-H2170 cells to cisplatin doses that were increased in week 4 and decreased in week 5. Overall, 44 genes were differentially expressed in both the NCI-H226 and NCI-H2170 cell lines. In the NCI-H2170 cell line, 24 genes had a twofold gene expression change from weeks 3 to 4. Real-time PCR found a significant correlation of the gene expression changes for seven genes of interest. This small time-ordered series identified novel genes associated with cisplatin resistance. This kind of analysis should be viewed as a first step towards building gene-regulatory networks.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA and Holt JT . (1999). J. Biol. Chem., 274, 18808–18812.
Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC and Fornace Jr AJ . (2000). Cancer Res., 60, 6101–6110.
Anderson IC, Sugarbaker DJ, Ganju RK, Tsarwhas DG, Richards WG, Sunday M, Kobzik L and Shipp MA . (1995). Cancer Res., 55, 4120–4126.
Anderson KM, Alrefai WA, Anderson CA, Ho Y, Jadko S, Ou D, Wu Y-B and Harris JE . (2002). Anticancer Res., 22, 75–82.
Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR and Bishop DK . (2000). J. Biol. Chem., 275, 23899–23903.
Bolon I, Devouassoux M, Robert C, Moro D, Brambilla C and Brambilla E . (1997). Am. J. Pathol., 150, 1619–1629.
Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM and Breit SN . (1997). Proc. Natl. Acad. Sci. USA, 94, 11514–11519.
Boulay A, Masson R, Chenard MP, El Fahime M, Cassard L, Bellocq JP, Sautes-Fridman C, Basset P and Rio MC . (2001). Cancer Res., 61, 2189–2193.
Brognard J, Clark AS, Ni Y and Dennis PA . (2001). Cancer Res., 61, 3986–3997.
Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S and Nakshatri H . (2001). J. Biol. Chem., 276, 9817–9824.
Citri A, Skaria KB and Yarden Y . (2003). Exp. Cell Res., 284, 54–65.
Clave E, Carosella ED, Gluckman E and Socie G . (1997). Leukemia, 11, 114–119.
Dabholkar M, Bostick-Bruton F, Weber C, Bohr VA, Egwuagu C and Reed E . (1992). J. Natl. Cancer Inst., 84, 1512–1517.
Dan S, Tsunoda T, Kitahara O, Yanagawa R, Zembutsu H, Katagiri T, Yamazaki K, Nakamura Y and Yamori T . (2002). Cancer Res., 62, 1139–1147.
De Larco JE, Wuertz BR, Manivel JC and Furcht LT . (2001). Cancer Res., 61, 2857–2861.
Delebecq TJ, Porte H, Zerimech F, Copin MC, Gouyer V, Dacquembronne E, Balduyck M, Wurtz A and Huet G . (2000). Clin. Cancer Res., 6, 1086–1092.
Dunkern TR, Fritz G and Kaina B . (2001). Mutat. Res., 486, 249–258.
Henderson YC, Chou M and Deisseroth AB . (1997). Br. J. Haematol., 96, 566–575.
Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS and Chin K-V . (2000). Cancer Res., 60, 4161–4166.
Lai WW, Chen FF, Wu MH, Chow NH, Su WC, Ma MC, Su PF, Chen H, Lin MY and Tseng YL . (2001). Ann. Thorac. Surg., 72, 1868–1876.
Lamendola DE, Duan Z, Yusuf RZ and Seiden MV . (2003). Cancer Res., 63, 2200–2205.
Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I and Lee JH . (2003). Cancer Res., 63, 4648–4655.
Li Q, Yu JJ, Mu C, Yunmbam MK, Slavsky D, Cross CL, Bostick-Bruton F and Reed E . (2000). Anticancer Res., 20, 645–652.
Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, Pretlow T, Elkahloun AG, Trepel JB and Kallioniemi OP . (2001). Oncogene, 20, 6718–6723.
Moynahan ME, Chiu JW, Koller BH and Jasin M . (1999). Mol. Cell., 4, 511–518.
Munster PN, Marchion DC, Basso AD and Rosen N . (2002). Cancer Res., 62, 3132–3137.
Noel AC, Lefebvre O, Maquoi E, VanHoorde L, Chenard MP, Mareel M, Foidart JM, Basset P and Rio MC . (1996). J. Clin. Invest., 97, 1924–1930.
Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD and Mulshine JL . (1996). J. Cell. Biochem., 24 (Suppl.), 32–91.
Plumb JA, Milroy R and Kaye SB . (1989). Cancer Res., 49, 4435–4440.
Rajeevan MS, Ranamukhaarachchi DG, Vernon SD and Unger ER . (2001). Methods, 25, 443–451.
Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN . (2000). Nat. Genet., 24, 236–244.
Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ and Qin J . (2000). Genes Dev., 14, 927–939.
Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson Jr HF and Hampton GM . (2003). Proc. Natl. Acad. Sci. USA, 100, 3410–3415.
Zhang J and Byrne CD . (1999). Biochem. J., 337 (Part 2), 231–241.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Whiteside, M., Chen, DT., Desmond, R. et al. A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance. Oncogene 23, 744–752 (2004). https://doi.org/10.1038/sj.onc.1207164
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207164
Keywords
This article is cited by
-
Chronological Pattern Exploration Algorithm for Gene Expression Data Clustering and Classification
Wireless Personal Communications (2018)
-
Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas
Modern Pathology (2008)
-
Post hoc pattern matching: assigning significance to statistically defined expression patterns in single channel microarray data
BMC Bioinformatics (2007)
-
Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells
Oncogene (2007)
-
Identification and immunotherapeutic targeting of antigens induced by chemotherapy
Nature Biotechnology (2006)